<VariationArchive VariationID="374308" VariationName="NM_014844.5(TECPR2):c.1319del (p.Leu440fs)" VariationType="Deletion" Accession="VCV000374308" Version="21" RecordType="classified" NumberOfSubmissions="9" NumberOfSubmitters="9" DateLastUpdated="2024-03-17" DateCreated="2017-01-16" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="361210" VariationID="374308">
      <GeneList>
        <Gene Symbol="TECPR2" FullName="tectonin beta-propeller repeat containing 2" GeneID="9895" HGNC_ID="HGNC:19957" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>14q32.31</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="14" Accession="NC_000014.9" start="102362941" stop="102502477" display_start="102362941" display_stop="102502477" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="14" Accession="NC_000014.8" start="102829299" stop="102968817" display_start="102829299" display_stop="102968817" Strand="+" />
          </Location>
          <OMIM>615000</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_014844.5(TECPR2):c.1319del (p.Leu440fs)</Name>
      <CanonicalSPDI>NC_000014.9:102432029:T:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>14q32.31</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="14" Accession="NC_000014.8" start="102898367" stop="102898367" display_start="102898367" display_stop="102898367" variantLength="1" positionVCF="102898366" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="14" Accession="NC_000014.9" start="102432030" stop="102432030" display_start="102432030" display_stop="102432030" variantLength="1" positionVCF="102432029" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>L440fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000014.8" sequenceAccession="NC_000014" sequenceVersion="8" change="g.102898367del" Assembly="GRCh37">
            <Expression>NC_000014.8:g.102898367del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_014844.4" sequenceAccession="NM_014844" sequenceVersion="4" change="c.1319delT">
            <Expression>NM_014844.4:c.1319delT</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_014844.3" sequenceAccession="NM_014844" sequenceVersion="3" change="c.1319delT">
            <Expression>NM_014844.3:c.1319delT</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000014.9" sequenceAccession="NC_000014" sequenceVersion="9" change="g.102432030del" Assembly="GRCh38">
            <Expression>NC_000014.9:g.102432030del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_042851.1" sequenceAccession="NG_042851" sequenceVersion="1" change="g.74119del">
            <Expression>NG_042851.1:g.74119del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001172631.3" sequenceAccession="NM_001172631" sequenceVersion="3" change="c.1319del">
            <Expression>NM_001172631.3:c.1319del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001166102.1" sequenceAccession="NP_001166102" sequenceVersion="1" change="p.Leu440fs">
            <Expression>NP_001166102.1:p.Leu440fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_014844.5" sequenceAccession="NM_014844" sequenceVersion="5" change="c.1319del" MANESelect="true">
            <Expression>NM_014844.5:c.1319del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_055659.2" sequenceAccession="NP_055659" sequenceVersion="2" change="p.Leu440fs">
            <Expression>NP_055659.2:p.Leu440fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001172631.3" sequenceAccession="NM_001172631" sequenceVersion="3" change="c.1319delT">
            <Expression>NM_001172631.3:c.1319delT</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA7357695" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="615000.0002" DB="OMIM" />
        <XRef Type="rs" ID="750908377" DB="dbSNP" />
      </XRefList>
      <FunctionalConsequence Value="protein truncation">
        <XRef ID="0015" DB="Variation Ontology" />
      </FunctionalConsequence>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00007" Source="Exome Aggregation Consortium (ExAC)" />
        <AlleleFrequency Value="0.00008" Source="The Genome Aggregation Database (gnomAD)" />
        <AlleleFrequency Value="0.00010" Source="Trans-Omics for Precision Medicine (TOPMed)" />
        <AlleleFrequency Value="0.00015" Source="The Genome Aggregation Database (gnomAD), exomes" />
        <AlleleFrequency Value="0.00060" Source="NHLBI Exome Sequencing Project (ESP) Exome Variant Server" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_014844.5(TECPR2):c.1319del (p.Leu440fs) AND Hereditary spastic paraplegia 49" Accession="RCV000414835" Version="17">
        <ClassifiedConditionList TraitSetID="9183">
          <ClassifiedCondition DB="MedGen" ID="C3542549">Hereditary spastic paraplegia 49</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-01-11" SubmissionCount="7">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_014844.5(TECPR2):c.1319del (p.Leu440fs) AND not provided" Accession="RCV001008810" Version="4">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-04-14" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_014844.5(TECPR2):c.1319del (p.Leu440fs) AND Hereditary spastic paraplegia" Accession="RCV003330660" Version="1">
        <ClassifiedConditionList TraitSetID="8750">
          <ClassifiedCondition DB="MedGen" ID="C0037773">Hereditary spastic paraplegia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-08-02" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-01-11" NumberOfSubmissions="9" NumberOfSubmitters="9" DateCreated="2017-01-16" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="Suggested Reading" Abbrev="Zhu et al., 2015">
          <ID Source="PubMed">25590979</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23176824</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26542466</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">33847017</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9183" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17564" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hereditary spastic paraplegia 49</ElementValue>
                <XRef ID="MONDO:0014016" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Spastic paraplegia 49, autosomal recessive</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IX, WITH DEVELOPMENTAL DELAY</ElementValue>
                <XRef Type="MIM" ID="615031" DB="OMIM" />
                <XRef Type="Allelic variant" ID="615000.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="615000.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="615000.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="615000.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="615000.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="615000.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="615000.0005" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">HSAN9</ElementValue>
                <XRef Type="MIM" ID="615031" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">TECPR2-related hereditary sensory and autonomic neuropathy with intellectual disability (TECPR2-HSAN with ID) is characterized by developmental delay and subsequent intellectual disability, behavioral abnormalities, neurologic manifestations (muscular hypotonia, sensory neuropathy with lower-limb hypo- or areflexia and ataxic gait), and autonomic dysfunction (including central hypoventilation and apnea, gastrointestinal dysmotility, dysphagia, and gastroesophageal reflux disease with recurrent aspiration). To date, more than 30 individuals with TECPR2-HSAN with ID have been identified.</Attribute>
                <XRef ID="NBK584409" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="13568" />
                <XRef ID="13568" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">36137062</ID>
                <ID Source="BookShelf">NBK584409</ID>
              </Citation>
              <XRef ID="320385" DB="Orphanet" />
              <XRef ID="C3542549" DB="MedGen" />
              <XRef ID="MONDO:0014016" DB="MONDO" />
              <XRef Type="MIM" ID="615031" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="8750" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="14327" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hereditary spastic paraplegia</ElementValue>
                <XRef ID="Hereditary+spastic+paraplegia/3383" DB="Genetic Alliance" />
                <XRef ID="MONDO:0019064" DB="MONDO" />
                <XRef ID="39912006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial spastic paraparesis</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">HSP</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">FSP</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6637" />
                <XRef ID="6637" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000508756" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000525862" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592992" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000576334" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000500041" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000529007" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000500218" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000525863" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301682</ID>
                <ID Source="BookShelf">NBK1509</ID>
              </Citation>
              <XRef ID="685" DB="Orphanet" />
              <XRef ID="C0037773" DB="MedGen" />
              <XRef ID="MONDO:0019064" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS303350" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="962852" SubmissionDate="2016-11-14" DateLastUpdated="2017-01-16" DateCreated="2017-01-16">
        <ClinVarSubmissionID localKey="chr14:102898367del|OMIM:615031" submittedAssembly="hg19" />
        <ClinVarAccession Accession="SCV000328784" DateUpdated="2017-01-16" DateCreated="2017-01-16" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2015-11-12">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">26542466</ID>
          </Citation>
          <Comment>Our laboratory reported three molecular diagnoses in DFNA5 (NM_004403.2, c.119dup), FLG (NM_002016.1, c.4279G&gt;A), and TECPR2 (NM_014844.3, c.1319del) in one individual with reported features which include delayed motor milestones, delayed speech, developmental regression, mild bilateral sensorineural hearing loss, hypotonia, hyporeflexia, dysmorphic features, short stature, hyperextensibility, ichthyosis, hypothyroidism, mild elevation of CK and eye anomalies. The c.1319del (p.L440fs) TECPR2 change has been reported in three unrelated Ashkenazi Jewish patients of non-Bukharian origin [PMID 26542466], either homozygous or compound heterozygous, leading to hereditary sensory-autonomic neuropathy. Heterozygotes are expected to be asymptomatic carriers.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Ethnicity>Ashkenazi Jew</Ethnicity>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">0</Age>
              <Age Type="maximum" age_unit="years">9</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
              <FamilyData NumFamiliesWithVariant="1" />
            </Sample>
            <Method>
              <TypePlatform>Next-gen sequencing</TypePlatform>
              <XRef DB="GTR" ID="GTR000508680.4" URL="http://www.ncbi.nlm.nih.gov/gtr/tests/508680/" />
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="VariantChromosomes" integerValue="2" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Homozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">7</Age>
              <Age Type="maximum" age_unit="years">13</Age>
              <AffectedStatus>unknown</AffectedStatus>
              <Gender>mixed</Gender>
              <FamilyData NumFamiliesWithVariant="2" />
            </Sample>
            <Method>
              <TypePlatform>Next-gen sequencing</TypePlatform>
              <XRef DB="GTR" ID="GTR000508680.4" URL="http://www.ncbi.nlm.nih.gov/gtr/tests/508680/" />
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="2" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="VariantChromosomes" integerValue="2" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="2" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TECPR2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_014844.3:c.1319del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="615031" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>Dual_diagnosis_variants</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2808436" SubmissionDate="2020-07-22" DateLastUpdated="2020-07-27" DateCreated="2020-07-27">
        <ClinVarSubmissionID localKey="SUB7681660" submittedAssembly="hg19" title="SUB7681660" />
        <ClinVarAccession Accession="SCV001423562" DateUpdated="2020-07-27" DateCreated="2020-07-27" Type="SCV" Version="1" SubmitterName="Institute of Human Genetics, University of Leipzig Medical Center" OrgID="506086" OrganizationCategory="clinic" OrgAbbreviation="UKL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-06-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This homozygous variant was identified by (trio-)exome sequencing in three individuals (9 month old female, 2 year old male and 3 year old male) with developmental delay and muscular hypotonia. The families are from Ashkenazi Jewish descent. Each parents are heterozygous carriers for this variant. This frameshift variant c.1319del, p.(Leu440Argfs*19) in exon 8/20 of TECPR2 has a minor allel frequency in the general population of 0.0001342 (gnomAD). Two publications (PMID: 25590979, 26542466) report four similarly affected patients with this variant (homozygous or compound heterozygous). The variant is already reported in ClinVar as pathogenic (ID: 374308). Biallelic truncating or missense variants have been described to cause "Spastic paraplegia 49, autosomal recessive" (Oz-Levi et al. Am J Hum Genet. 2012, PMID: 23176824). Taken together, we classify this variant as pathogenic based on the ACMG recommendations (Richards et al., 2015, PMID 25741868; criteria: PVS1 PS4_MOD PM2).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation Type="general">
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>inherited</Origin>
              <Ethnicity>Ashkenazi Jewish, Middle Eastern</Ethnicity>
              <GeographicOrigin>United States of America, Eastern Europe, Israel</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">1</Age>
              <Age Type="maximum" age_unit="years">18</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>mixed</Gender>
              <FamilyData NumFamiliesWithVariant="7" />
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="7" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Homozygote" integerValue="5" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="CompoundHeterozygote" integerValue="2" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TECPR2">
              <Name>tectonin beta-propeller repeat containing 2</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_014844.4:exon 8</GeneLocation>
          </Location>
          <OtherNameList>
            <Name Type="SubmitterVariantId">In-02</Name>
          </OtherNameList>
          <FunctionalConsequence Value="protein truncation">
            <XRef DB="Variation Ontology" ID="0015" URL="http://purl.obolibrary.org/obo/VariO_0015" />
          </FunctionalConsequence>
          <AttributeSet>
            <Attribute Type="HGVS">NM_014844.4:c.1319del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="615031" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB7681660</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3692611" SubmissionDate="2021-10-19" DateLastUpdated="2021-10-25" DateCreated="2021-09-19">
        <ClinVarSubmissionID localKey="615000.0002_NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IX, WITH DEVELOPMENTAL DELAY" title="TECPR2, 1-BP DEL, 1319T_NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IX, WITH DEVELOPMENTAL DELAY" />
        <ClinVarAccession Accession="SCV001890895" DateUpdated="2021-10-25" DateCreated="2021-09-19" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-10-19">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In an Ashkenazi Jewish patient (patient 2) with hereditary sensory and autonomic neuropathy type IX with developmental delay (HSAN9; 615031), Heimer et al. (2016) identified homozygosity for 1-bp deletion (c.1319delT, NM_001172631) in exon 8 of the TECPR2 gene, predicted to result in a frameshift and premature termination (Leu440ArgfsTer19). The mutation was not present in the NHLBI Exome Sequencing Project and dbSNP (build 38) databases or in an in-house database of 240 exomes; it was identified in heterozygous state in 3 of 900 exomes in the Hadassah in-house database and in 9 of 2,000 exomes from the Ashkenazi exome project. In another Ashkenazi Jewish patient (patient 1), Heimer et al. (2016) identified c.1319delT in compound heterozygous state with a c.566C-T transition in exon 3, resulting in a thr189-to-ile (T189I; 615000.0003) substitution. In patient 3, of Ashkenazi and Turkish descent, c.1319delT was found in compound heterozygous state with a previously identified c.3416delT mutation (615000.0001). The mutations segregated with the phenotype in all 3 families.</Attribute>
              <Citation>
                <ID Source="PubMed">26542466</ID>
              </Citation>
              <XRef DB="OMIM" ID="615031" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In 5 patients with HSAN9, Neuser et al. (2021) identified the c.1319del founder mutation in the TECPR2 gene, in homozygosity in 4 and in compound heterozygosity in 1. They noted that the minor allele frequency of the c.1319del variant was 37/275,698 in only heterozygous state in the gnomAD database.</Attribute>
              <Citation>
                <ID Source="PubMed">33847017</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TECPR2" />
          </GeneList>
          <Name>TECPR2, 1-BP DEL, 1319T</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 1319T</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="615000.0002" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IX, WITH DEVELOPMENTAL DELAY</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4081731" SubmissionDate="2022-02-09" DateLastUpdated="2022-04-23" DateCreated="2022-04-23">
        <ClinVarSubmissionID localKey="NM_014844.5:c.1319del|Autosomal recessive spastic paraplegia type 49" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002088006" DateUpdated="2022-04-23" DateCreated="2022-04-23" Type="SCV" Version="1" SubmitterName="Natera, Inc." OrgID="500034" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-09-24">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_014844.5:c.1319del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Autosomal recessive spastic paraplegia type 49</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10993736</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5467033" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_014844.5:c.1319del|OMIM:615031" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002815506" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-08-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_014844.5:c.1319del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="615031" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2306604" SubmissionDate="2022-04-27" DateLastUpdated="2023-03-04" DateCreated="2020-03-16">
        <ClinVarSubmissionID localKey="GDXSV:225509" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV001168611" DateUpdated="2023-03-04" DateCreated="2020-03-16" Type="SCV" Version="4" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-04-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 33847017, 27959697, 26542466, 25590979, 32209221, 33884296)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TECPR2" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:743762</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_014844.3:c.1319del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_103_20220427054204</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_57_20210930044205</SubmissionName>
          <SubmissionName>SUB6425168</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7556763" SubmissionDate="2023-10-02" DateLastUpdated="2023-10-07" DateCreated="2023-10-07">
        <ClinVarSubmissionID localKey="NM_014844.4:c.1319delT|MedGen:C0037773" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004038215" DateUpdated="2023-10-07" DateCreated="2023-10-07" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-08-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">25590979</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">33847017</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26542466</ID>
          </Citation>
          <Comment>Variant summary: TECPR2 c.1319delT (p.Leu440ArgfsX19) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant allele was found at a frequency of 0.00015 in 244296 control chromosomes (gnomAD). This frequency is not significantly higher than estimated for a pathogenic variant in TECPR2 causing Hereditary Spastic Paraplegia, Type 49 (0.00015 vs 0.0011), allowing no conclusion about variant significance. c.1319delT has been reported in the literature as a biallelic genotype in multiple individuals affected with Hereditary Spastic Paraplegia, Type 49 (e.g. Zhu_2015, Heimer_2016, Neuser_2021). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 26542466, 33847017, 25590979). Eight ClinVar submitters have assessed the variant since 2014, and all submitters classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TECPR2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_014844.4:c.1319delT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0037773" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13878306</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7134452" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2023-03-04">
        <ClinVarSubmissionID localKey="3d5816ef414ff97bd988bc0a61b9c229144c1f6806d0d2d62bdf448d8abb5ded|OMIM:615031" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003828007" DateUpdated="2024-02-04" DateCreated="2023-03-04" Type="SCV" Version="2" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-04-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_014844.5:c.1319del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="615031" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12922107</SubmissionName>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1859625" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2019-08-14">
        <ClinVarSubmissionID localKey="256044|MedGen:C3542549" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000965238" DateUpdated="2024-02-14" DateCreated="2019-08-14" Type="SCV" Version="6" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">23176824</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25590979</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25590979</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26542466</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Leu440Argfs*19) in the TECPR2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TECPR2 are known to be pathogenic (PMID: 23176824, 25590979). This variant is present in population databases (rs750908377, gnomAD 0.3%). This premature translational stop signal has been observed in individual(s) with autonomic dysfunction and intellectual disability (PMID: 25590979, 26542466). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 374308). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TECPR2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000014.8:g.102898367del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3542549" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7556763" TraitType="Disease" MappingType="XRef" MappingValue="C0037773" MappingRef="MedGen">
        <MedGen CUI="C0037773" Name="Hereditary spastic paraplegia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7134452" TraitType="Disease" MappingType="XRef" MappingValue="615031" MappingRef="OMIM">
        <MedGen CUI="C3542549" Name="Hereditary spastic paraplegia 49" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3692611" TraitType="Disease" MappingType="Name" MappingValue="NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IX, WITH DEVELOPMENTAL DELAY" MappingRef="Preferred">
        <MedGen CUI="C3542549" Name="Hereditary spastic paraplegia 49" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2808436" TraitType="Disease" MappingType="XRef" MappingValue="615031" MappingRef="OMIM">
        <MedGen CUI="C3542549" Name="Hereditary spastic paraplegia 49" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="962852" TraitType="Disease" MappingType="XRef" MappingValue="615031" MappingRef="OMIM">
        <MedGen CUI="C3542549" Name="Hereditary spastic paraplegia 49" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5467033" TraitType="Disease" MappingType="XRef" MappingValue="615031" MappingRef="OMIM">
        <MedGen CUI="C3542549" Name="Hereditary spastic paraplegia 49" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2306604" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1859625" TraitType="Disease" MappingType="XRef" MappingValue="C3542549" MappingRef="MedGen">
        <MedGen CUI="C3542549" Name="Hereditary spastic paraplegia 49" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4081731" TraitType="Disease" MappingType="Name" MappingValue="Autosomal recessive spastic paraplegia type 49" MappingRef="Preferred">
        <MedGen CUI="C3542549" Name="Hereditary spastic paraplegia 49" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

